PHARMAC performance 2017/18 Q1
Performance data to 30 September 2017
Output Class 1: Decision-making
Measure: Savings are made to meet the cost of growth and to enable new investments
Status: On track. Savings are generated to meet the cost of future volume growth and allow for new investments.
Measure: Savings are made from hospital medicines to enable new investments.
Status: On track. Five year cumulative savings to the health system of all decisions since 2013/14 is $206.5 million for hospital medicines.
Five year cumulative savings to the health system of all decisions in 2017/18 is $19.58 million for hospital medicines.
Measure: The total value and number of hospital medical devices under contract increases.
Status: On track. Between 1 July 2017 and 30 September 2017, the Pharmaceutical Schedule increased by around 18,000 lines items, with contracts increasing to approximately $143 million of annual expenditure.
Output Class 2: Influencing medicines use
Measure: DHB hospital engagement with PHARMAC compared with previous year.
Status: On track. All DHBs share information on a quarterly basis showing how their baseline use of wound care products is tracking in advance of a move to market share agreements.
Measure: Survey of attendants at a PHARMAC Seminar show a positive professional change in optimal use behaviour as a result of attendance.
Status: No seminars from 2017/18 have been surveyed yet.
Measure: Medicines use community health programmes are delivered to a range of health and community workers.
Status: On track. We have increased our number of WOC partners from 11 to 13 for the quarter ending 30 September 2017.
Measure: Low medicine stock situations are identified and managed so that there are no clinically meaningful consequences to patients.
Status: On track. PHARMAC has worked with suppliers to identify, monitor and manage all low medicine stock reports and taken actions to meet patients’ medicine needs. The BCG vaccine ran out of stock in 2017 due to a worldwide shortage. In response, PHARMAC managed supply by worked closely with the Ministry of Health and vaccinators to minimise any potential impact for patients.
Output Class 3: Providing policy advice and support
Measure: PHARMAC staff participate in and contribute to wider sector forums.
Status: On track. PHARMAC continues to actively instigate and participate in various engagements across the health sector.
Measure: All rebates are collected and distributed to DHBs in accordance with
Status: On track.
Last updated: 14 December 2017